The State Drug Administration approves Chinese medicine Innovation drugs, Guang Qiancao total flavonoid capsules listing

Recently, the State Drug Administration approved the listing application for listing and registration of Class 1.2 Chinese Medicine Innovation Pharmaceuticals and Capylus Capylus Capsules.The main ingredient of the drug is the total flavonoid ingredients from the Cantonese Cao.

The medicine carried out random, double -blindness, parallel controller, and multi -center clinical trials. The results of clinical trial research showed that there were statistical differences between the control groups of the placebo. It can be used for the treatmentEssence

This variety will provide new treatment options for patients with clinical -related diseases.The drug supervision and management department will strengthen the supervision of the drug after listing to protect the safety of patients' medication.

Source: National Drug Administration

- END -